Illinois 104th General Assembly Status: Introduced 6 D cosponsors

HB4219      — SCH CD-EPINEPHRINE DELIVERY

Last action — Rule 19(a) / Re-referred to Rules Committee

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the House. Introduced December 04, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Amends the School Code. Changes the term "epinephrine injector" to "epinephrine delivery system" in a provision regarding the self-administration, self-carry, and administration of epinephrine delivery systems. Defines "epinephrine delivery system" as any form of epinephrine that is approved by the United States Food and Drug Administration and that is used to administer epinephrine into the human body to prevent or treat a life-threatening allergic reaction. Requires the entity or individual conducting the training curriculum to recognize and respond to anaphylaxis to issue a certificate to each person who successfully completes the anaphylaxis training program. Allows the anaphylaxis training to include the proper techniques for administering non-injector epinephrine options. Effective July 30, 2026.

Bill Text

We don't have the full text on file for this bill yet.

Read HB4219 on the official Illinois source →

Action History

  1. Rule 19(a) / Re-referred to Rules Committee

  2. Added Chief Co-Sponsor Rep. Michelle Mussman

  3. Assigned to Elementary & Secondary Education: Administration, Licensing & Charter Schools

  4. Added Co-Sponsor Rep. Harry Benton

  5. Added Chief Co-Sponsor Rep. Janet Yang Rohr

  6. Chief Co-Sponsor Changed to Rep. Joyce Mason

  7. Added Chief Co-Sponsor Rep. Joyce Mason

  8. Added Chief Co-Sponsor Rep. Sharon Chung

  9. Referred to Rules Committee

  10. First Reading

  11. Filed with the Clerk by Rep. Martha Deuter

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 5 co-sponsors · 177 not signed on

Sponsors (1)

Co-sponsors (5)

Not signed on (177)

177 members have not signed on to this bill.

Show all 177 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare education
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB4219      do?
Amends the School Code. Changes the term "epinephrine injector" to "epinephrine delivery system" in a provision regarding the self-administration, self-carry, and administration of epinephrine delivery systems. Defines "epinephrine delivery system" as any form of epinephrine that is approved by the United States Food and Drug Administration and that is used to administer epinephrine into the human body to prevent or treat a life-threatening allergic reaction. Requires the entity or individual conducting the training curriculum to recognize and respond to anaphylaxis to issue a certificate to each person who successfully completes the anaphylaxis training program. Allows the anaphylaxis training to include the proper techniques for administering non-injector epinephrine options. Effective July 30, 2026.
Who sponsors HB4219     ?
HB4219      is sponsored by Martha Deuter (Democrat), Joyce Mason (Democrat), Sharon Chung (Democrat), Janet Yang Rohr (Democrat), Michelle Mussman (Democrat), and Harry Benton (Democrat).
What is the current status of HB4219     ?
This bill has been introduced in the House. Introduced December 04, 2025. It must pass committee before a floor vote.
Where can I track HB4219     ?
Track HB4219      free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB4219     

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB4219     

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →